相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
Chang Liu et al.
NATURE IMMUNOLOGY (2020)
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages
Yannick De Vlaeminck et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
Marine Leclerc et al.
NATURE COMMUNICATIONS (2019)
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent
Katrijn Broos et al.
CANCERS (2019)
Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production
Katrijn Broos et al.
VACCINES (2019)
Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq et al.
THERANOSTICS (2019)
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex
Joseph R. Podojil et al.
JOURNAL OF IMMUNOLOGY (2018)
Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation
Yuan Ding et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies
Sabrina Rizzolio et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Deletion of Neuropilin 1 from Microglia or Bone Marrow-Derived Macrophages Slows Glioma Progression
Jeremy Tetsuo Miyauchi et al.
CANCER RESEARCH (2018)
The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation
Claudia Dollt et al.
ONCOTARGET (2017)
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers
Katrijn Broos et al.
ONCOTARGET (2017)
Multifaceted Role of Neuropilins in the immune System: Potential Targets for immunotherapy
Sohini Roy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity
Kosuke Kawaguchi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Majken Wallerius et al.
CANCER RESEARCH (2016)
Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity
Shimin Wang et al.
SCIENTIFIC REPORTS (2016)
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway
Fanwei Zeng et al.
ANTI-CANCER DRUGS (2014)
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
Amita Patnaik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
Damya Laoui et al.
CANCER RESEARCH (2014)
Monocyte Subpopulations in Angiogenesis
Heather J. Dalton et al.
CANCER RESEARCH (2014)
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
Colin D. Weekes et al.
INVESTIGATIONAL NEW DRUGS (2014)
Location, Location, Location: Macrophage Positioning within Tumors Determines Pro- or Antitumor Activity
Lee B. Rivera et al.
CANCER CELL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Inhibitory Effect of Neuropilin-1 Monoclonal Antibody (NRP-1 MAb) on Glioma Tumor in Mice
Lukui Chen et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M. Delgoffe et al.
NATURE (2013)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi et al.
CANCER RESEARCH (2012)
Estrogen Promotes ER-Negative Tumor Growth and Angiogenesis through Mobilization of Bone Marrow-Derived Monocytes
Vandana Iyer et al.
CANCER RESEARCH (2012)
Interleukin-12 (IL-12)/IL-10 Ratio as a Marker of Disease Severity in Crimean-Congo Hemorrhagic Fever
Dionysios C. Watson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer
Steve Schoonooghe et al.
IMMUNOBIOLOGY (2012)
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
Wiebke Hansen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mechanism for platelet reduction in anti-neuropilin-1 (MNRP1685A)-treated phase I patients
W. C. Darbonne et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular Carcinoma
Mathieu Berge et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
Interacting Roles of Immune Mechanisms and Viral Load in the Pathogenesis of Crimean-Congo Hemorrhagic Fever
Ana Saksida et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
Karine Breckpot et al.
JOURNAL OF VIROLOGY (2010)
Inhibition of Neuropilin-1 by RNA-Interference and its Angiostatic Potential in the Treatment of Hepatocellular Carcinoma
E. Raskopf et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2010)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neuropilins: structure, function and role in disease
Caroline Pellet-Many et al.
BIOCHEMICAL JOURNAL (2008)
Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition
Milka Sarris et al.
IMMUNITY (2008)
Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells
Lin Lu et al.
LEUKEMIA & LYMPHOMA (2008)
Targeting neuropilin 1 as an antitumor strategy in lung cancer
Tse-Ming Hong et al.
CLINICAL CANCER RESEARCH (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library
We-Ching Liang et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer
Sarah Bourbie-Vaudaine et al.
JOURNAL OF IMMUNOLOGY (2006)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Neuropilin-1: a surface marker of regulatory T cells
D Bruder et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
K Breckpot et al.
JOURNAL OF GENE MEDICINE (2003)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo
G Schuch et al.
BLOOD (2002)
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
CJ Kuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
ML Gagnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
